Clincosm LogoSign in Get a demo

Hypnosis as a Treatment of Chronic Widespread Pain in General Practice. A Pilot Study.

Sponsor
University of Oslo (Other)
Overall Status
Completed
CT.gov ID
NCT00521807
Collaborator
(none)
18
Enrollment
1
Location
2
Arms
50
Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Objective: The study was performed to evaluate the effect of a standardized hypnosis treatment used in general practice for patients with chronic widespread pain (CWP).

Design: A randomized control group-controlled study. Setting and subjects: 16 patients were randomized into a treatment group or a control group, each constituting eight patients. Seven patients in the treatment group completed the schedule. After the control period, five of the patients in the control group also received treatment, making a total of 12 patients having completed the treatment sessions.

Intervention: The intervention group went through a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting for about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension and increasing self-efficacy.

Main outcome measures: A questionnaire was developed in order to calibrate the symptoms before and after the 10 weeks period, and the results were interpolated into a scale from 0 to 100, increasing numbers representing increasing suffering.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hypnosis
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date :
Mar 1, 2001
Actual Study Completion Date :
May 1, 2005

Arms and Interventions

Arm Intervention/Treatment
No Intervention: A 1
Experimental: A 2

Treatment group

Procedure: Hypnosis
a standardized hypnosis treatment with ten consecutive therapeutic sessions once a week,

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Chronic widespread pain for at least three months and at most five years.
    Exclusion Criteria:
    • Patients having primarily other organic diseases or serious psychiatric disorders were excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 1) Institute of General Practice and Community Medicine, University of Oslo Oslo Norway 0318

    Sponsors and Collaborators

    • University of Oslo

    Investigators

    • Principal Investigator: Jan R Grondahl, Dr, The Institute of General Practice and Community Medicine, University of Oslo, Norway.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00521807
    Other Study ID Numbers:
    • 26035831907
    First Posted:
    Aug 28, 2007
    Last Update Posted:
    Oct 20, 2008
    Last Verified:
    Aug 1, 2007
    Keywords provided by , ,
    Hypnosis,
    Chronic widespread pain,
    CWP,
    General Practice
    Additional relevant MeSH terms:
    Chronic Pain

    Study Results

    No Results Posted as of Oct 20, 2008